NCT02151981 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- AEs from start of study drug until 28 days post treatment discontinuation up to 4 years and 7 months (at the time of analysis)
- Other-event reporting threshold
- 5%
Systematic assessment due to regular investigator assessment at study visits.
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Osimertinib 80 mg | 84 / 279 | 275 / 279 | 188 / 279 |
| Chemotherapy | 36 / 136 | 134 / 136 | 93 / 136 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 279
- num Events
- 1
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 136
- num Events
- 3
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 279
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 136
- num Events
- 1
- term
- Disseminated intravascular coagulation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 279
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 136
- num Events
- 1
- term
- Febrile neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 279
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 136
- num Events
- 0
- term
- Leukocytosis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 279
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 136
- num Events
- 1
- term
- Leukopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 279
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 136
- num Events
- 1
- term
- Neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 279
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 136
- num Events
- 1
- term
- Angina pectoris
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 279
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 136
- num Events
- 1
- term
- Atrial fibrillation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 279
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 136
- num Events
- 0
- term
- Intestinal ischaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 279
- num Events
- 6
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 136
- num Events
- 0
- term
- Pneumonia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 279
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 136
- num Events
- 0
- term
- Electrocardiogram QT prolonged
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 279
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 136
- num Events
- 0
- term
- Back pain
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 32
- num At Risk
- 279
- num Events
- 38
- group Id
- EG001
- num Affected
- 35
- num At Risk
- 136
- num Events
- 45
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 14
- num At Risk
- 279
- num Events
- 33
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 136
- num Events
- 12
- term
- Leukopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 14
- num At Risk
- 279
- num Events
- 24
- group Id
- EG001
- num Affected
- 17
- num At Risk
- 136
- num Events
- 26
- term
- Neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 18
- num At Risk
- 279
- num Events
- 30
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 136
- num Events
- 15
- term
- Thrombocytopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 279
- num Events
- 2
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 136
- num Events
- 7
- term
- Tinnitus
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 279
- num Events
- 1
- group Id
- EG001
- num Affected
- 8
- num At Risk
- 136
- num Events
- 10
- term
- Lacrimation increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 279
- num Events
- 13
- group Id
- EG001
- num Affected
- 11
- num At Risk
- 136
- num Events
- 11
- term
- Abdominal pain upper
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 50
- num At Risk
- 279
- num Events
- 56
- group Id
- EG001
- num Affected
- 48
- num At Risk
- 136
- num Events
- 94
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 123
- num At Risk
- 279
- num Events
- 226
- group Id
- EG001
- num Affected
- 14
- num At Risk
- 136
- num Events
- 21
- term
- Diarrhoea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 64
- num At Risk
- 279
- num Events
- 75
- group Id
- EG001
- num Affected
- 66
- num At Risk
- 136
- num Events
- 144
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 48
- num At Risk
- 279
- num Events
- 70
- group Id
- EG001
- num Affected
- 22
- num At Risk
- 136
- num Events
- 26
- term
- Stomatitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 42
- num At Risk
- 279
- num Events
- 53
- group Id
- EG001
- num Affected
- 27
- num At Risk
- 136
- num Events
- 49
- term
- Vomiting
Complete source fields
- description
- Systematic assessment due to regular investigator assessment at study visits.
- event Groups
- deaths Num Affected
- 188
- deaths Num At Risk
- 279
- description
- Daily single dose of Osimertinib 80mg
- id
- EG000
- other Num Affected
- 275
- other Num At Risk
- 279
- serious Num Affected
- 84
- serious Num At Risk
- 279
- title
- Osimertinib 80 mg
- deaths Num Affected
- 93
- deaths Num At Risk
- 136
- description
- Platinum-based doublet chemotherapy
- id
- EG001
- other Num Affected
- 134
- other Num At Risk
- 136
- serious Num Affected
- 36
- serious Num At Risk
- 136
- title
- Chemotherapy
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 32
- num At Risk
- 279
- num Events
- 38
- group Id
- EG001
- num Affected
- 35
- num At Risk
- 136
- num Events
- 45
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 14
- num At Risk
- 279
- num Events
- 33
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 136
- num Events
- 12
- term
- Leukopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 14
- num At Risk
- 279
- num Events
- 24
- group Id
- EG001
- num Affected
- 17
- num At Risk
- 136
- num Events
- 26
- term
- Neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 18
- num At Risk
- 279
- num Events
- 30
- group Id
- EG001
- num Affected
- 10
- num At Risk
- 136
- num Events
- 15
- term
- Thrombocytopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 279
- num Events
- 2
- group Id
- EG001
- num Affected
- 7
- num At Risk
- 136
- num Events
- 7
- term
- Tinnitus
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 279
- num Events
- 1
- group Id
- EG001
- num Affected
- 8
- num At Risk
- 136
- num Events
- 10
- term
- Lacrimation increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 10
- num At Risk
- 279
- num Events
- 13
- group Id
- EG001
- num Affected
- 11
- num At Risk
- 136
- num Events
- 11
- term
- Abdominal pain upper
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 50
- num At Risk
- 279
- num Events
- 56
- group Id
- EG001
- num Affected
- 48
- num At Risk
- 136
- num Events
- 94
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 123
- num At Risk
- 279
- num Events
- 226
- group Id
- EG001
- num Affected
- 14
- num At Risk
- 136
- num Events
- 21
- term
- Diarrhoea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 64
- num At Risk
- 279
- num Events
- 75
- group Id
- EG001
- num Affected
- 66
- num At Risk
- 136
- num Events
- 144
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 48
- num At Risk
- 279
- num Events
- 70
- group Id
- EG001
- num Affected
- 22
- num At Risk
- 136
- num Events
- 26
- term
- Stomatitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 42
- num At Risk
- 279
- num Events
- 53
- group Id
- EG001
- num Affected
- 27
- num At Risk
- 136
- num Events
- 49
- term
- Vomiting
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 279
- num Events
- 1
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 136
- num Events
- 3
- term
- Anaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 279
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 136
- num Events
- 1
- term
- Disseminated intravascular coagulation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 279
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 136
- num Events
- 1
- term
- Febrile neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 279
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 136
- num Events
- 0
- term
- Leukocytosis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 279
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 136
- num Events
- 1
- term
- Leukopenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 279
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 136
- num Events
- 1
- term
- Neutropenia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 279
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 136
- num Events
- 1
- term
- Angina pectoris
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 279
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 136
- num Events
- 1
- term
- Atrial fibrillation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 279
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 136
- num Events
- 0
- term
- Intestinal ischaemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 279
- num Events
- 6
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 136
- num Events
- 0
- term
- Pneumonia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 279
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 136
- num Events
- 0
- term
- Electrocardiogram QT prolonged
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Musculoskeletal and connective tissue disorders
- source Vocabulary
- MedDRA 21.1
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 279
- num Events
- 2
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 136
- num Events
- 0
- term
- Back pain
- time Frame
- AEs from start of study drug until 28 days post treatment discontinuation up to 4 years and 7 months (at the time of analysis)
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle